Literature DB >> 22052644

Osteoid osteoma and osteoblastoma.

Kivanc I Atesok1, Benjamin A Alman, Emil H Schemitsch, Amos Peyser, Henry Mankin.   

Abstract

Osteoid osteoma and osteoblastoma are commonly seen benign osteogenic bone neoplasms. Both tumors are typically seen in the second decade of life, with a notable predilection in males. Histologically, these tumors resemble each other, with characteristically increased osteoid tissue formation surrounded by vascular fibrous stroma and perilesional sclerosis. However, osteoblastomas are larger than osteoid osteomas, and they exhibit greater osteoid production and vascularity. Clinically, osteoid osteoma most commonly occurs in the long bones (eg, femur, tibia). The lesions cause night pain that is relieved with nonsteroidal anti-inflammatory drugs (NSAIDs). Osteoblastoma is most frequently located in the axial skeleton, and the pain is usually not worse at night and is less likely to be relieved with NSAIDs. Osteoblastoma can be locally aggressive; osteoid osteoma lacks growth potential. Osteoid osteoma may be managed nonsurgically with NSAIDs. When surgery is required, minimally invasive methods (eg, CT-guided excision, radiofrequency ablation) are preferred. Osteoblastoma has a higher rate of recurrence than does osteoid osteoma, and patients must be treated surgically with intralesional curettage or en bloc resection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22052644     DOI: 10.5435/00124635-201111000-00004

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  50 in total

1.  Arthroscopic excision of juxtaarticular cancellous osteoid osteoma in the talar neck.

Authors:  Kai Gao; Yinghui Hua; Shiyi Chen; Yunxia Li; Qingfeng Xin
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-06-24       Impact factor: 4.342

Review 2.  Osteoblastoma of the elbow: analysis of 13 patients and literature review.

Authors:  Andrea Angelini; Andrès Felipe Varela-Osorio; Giulia Trovarelli; Antonio Berizzi; Gabriele Zanotti; Pietro Ruggieri
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-06-20

3.  Surgical treatment options for aggressive osteoblastoma in the mobile spine.

Authors:  Liang Jiang; Xiao Guang Liu; Chao Wang; Shao Min Yang; Chen Liu; Feng Wei; Feng Liang Wu; Hua Zhou; Lei Dang; Zhong Jun Liu
Journal:  Eur Spine J       Date:  2015-04-07       Impact factor: 3.134

Review 4.  Tumors of the spine.

Authors:  Mert Ciftdemir; Murat Kaya; Esref Selcuk; Erol Yalniz
Journal:  World J Orthop       Date:  2016-02-18

5.  Bone Tumor Diagnosis Using a Naïve Bayesian Model of Demographic and Radiographic Features.

Authors:  Bao H Do; Curtis Langlotz; Christopher F Beaulieu
Journal:  J Digit Imaging       Date:  2017-10       Impact factor: 4.056

6.  Case study of radial fibrolamellar bone tissues in the outer cortex of basal sauropods.

Authors:  Benjamin Jentgen-Ceschino; Koen Stein; Valentin Fischer
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2020-01-13       Impact factor: 6.237

Review 7.  Osteoblastoma of the clavicle at the site of a previous fracture-first case report and review of the literature.

Authors:  Adriana C Moreira; David I Suster; Sterling Ellis Eide; Daniel I Rosenthal; Connie Y Chang
Journal:  Skeletal Radiol       Date:  2019-03-08       Impact factor: 2.199

8.  Is Navigation-guided En Bloc Resection Advantageous Compared With Intralesional Curettage for Locally Aggressive Bone Tumors?

Authors:  Germán L Farfalli; Jose I Albergo; Nicolas S Piuzzi; Miguel A Ayerza; D Luis Muscolo; Lucas E Ritacco; Luis A Aponte-Tinao
Journal:  Clin Orthop Relat Res       Date:  2018-03       Impact factor: 4.176

9.  Osteoid Osteoma of the Ulnar Head-An Uncommon Cause of Ulnar Wrist Pain.

Authors:  Pablo Valle; Raphael Rolland; Michel Chammas
Journal:  J Wrist Surg       Date:  2015-11

Review 10.  Osteoid osteoma: multimodality imaging with focus on hybrid imaging.

Authors:  Ujwal Bhure; Justus E Roos; Klaus Strobel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-19       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.